Table 1 Baseline demographic and clinical parameters of the study population.

From: The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality

Parameters

Control group (N = 594)

PEP/HCQ group (N = 574)

P value

Mean age (years ± SD)

35.1 ± 10.4

35.0 ± 10.4

0.845

18–45 years (N = 986)

500 (84.2%)

486 (84.7%)

0.816

 > 45–65 years (N = 166)

85 (14.3%)

81 (14.1%)

0.922

 > 65 years (N = 16)

9(1.5%)

7 (1.2%)

0.663

Male (N = 865)

428 (72.1%)

437 (76.1%)

0.112

Female (N = 303)

166 (27.9%)

137 (23.9%)

0.112

Smoker (N = 101)

51 (8.6%)

50 (8.7%)

0.939

Alcohol consumer (N = 234)

113 (19.0%)

121 (21.1%)

0.380

Diabetes (N = 43)

23 (3.9%)

20 (3.5%)

0.725

Hypertension (N = 41)

25 (4.2%)

16 (2.8%)

0.187

Coronary artery disease (N = 3)

3 (0.5%)

0(0.0%)

0.088

Hypothyroidism (N = 11)

7 (1.2%)

4 (0.7%)

0.394

Bronchial asthma (N = 1)

0 (0.0%)

1 (0.2%)

0.308